Despite being necessary for life outside of the womb, a baby’s lungs are some of the last structures to finish developing during pregnancy. As a result, the vast majority of very premature infants require some form of breathing support to survive.
Current non-invasive breathing support systems attempt to keep the lungs open and inflated between breaths by providing a positive air pressure or flow to the infant’s respiratory system. However, due to various leaks (which are unaccounted for) clinicians are forced to use a trial and error method when setting the level of support.
Delivering a pressure which is too high or too low can have serious health consequences for the baby. It results in slower physical development, increased length of stay in the neonatal intensive care unit (NICU) and higher morbidity rates later in life.
“We don’t know what pressure is actually being delivered to the lungs.”
“We are currently making decisions on best-guessed data.”
“A baby will open their mouth and suddenly you lose all that pressure.”
- NICU Respiratory Manager
Ventora Medical is developing a device that will provide continuous, real-time monitoring of the airway pressure, without adding any invasiveness to the current treatment. Ventora's solution will allow clinicians to tailor treatment to an individual patient, enabling proactive respiratory support. Integrating with existing non-invasive respiratory support systems, Ventora’s solution requires minimal procedural change and guides clinical decision making. The result is optimal lung function development and improved health outcomes of infants in the NICU.